Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

MPA: a treatment option for lymphocytic colitis and mesalamine-induced interstitial nephritis.

MPA: a treatment option for lymphocytic colitis and mesalamine-induced interstitial nephritis. Inflamm Bowel Dis. 2012 Mar; 18(3):E599-600.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.